论文部分内容阅读
目的分析应用重组人干扰素α-1b注射液联合匹多莫德口服溶液治疗扁平疣的临床效果。方法 200例扁平疣患者随机分为实验组和对照组,对照组单纯采用重组人干扰素α-1b注射液治疗,实验组采用重组人干扰素α-1b注射液联合匹多莫德口服溶液治疗,对比分析两组患者的临床治疗效果。结果实验组有效率(96.00%)明显高于对照组(56.00%),差异有统计学意义(P<0.05)。结论应用重组人干扰素α-1b注射液联合匹多莫德口服溶液治疗扁平疣的临床效果显著,安全可靠。
Objective To analyze the clinical efficacy of recombinant human interferon α-1b injection combined with pidotimod oral solution in the treatment of flat warts. Methods 200 cases of flat warts were randomly divided into experimental group and control group. The control group was treated with recombinant human interferon α-1b only. The experimental group was treated with recombinant human interferon α-1b and pidotomide oral solution , Comparative analysis of two groups of patients with clinical treatment. Results The effective rate of the experimental group (96.00%) was significantly higher than that of the control group (56.00%), the difference was statistically significant (P <0.05). Conclusion The clinical efficacy of recombinant human interferon α-1b injection and pidotimod oral solution in the treatment of flat warts is remarkable, safe and reliable.